Article

Pain and Depressive Symptoms Linked in Patients With Psoriatic Arthritis

There is an association between pain and depressive symptoms in patients with psoriatic arthritis. Changes in pain and depressive symptoms are predicted primarily by their measurements at the previous visit.

There is an association between pain and depressive symptoms in patients with psoriatic arthritis (PsA). Changes in pain and depressive symptoms are predicted primarily by their measurements at the previous visit.

Husted and associates monitored 394 patients over a mean period of 7.5 years. Annual assessments included swollen joint count (SJC), Health Assessment Questionnaire, and the Medical Outcomes Survey Short Form 36 (SF-36).

The strongest predictors of changes in pain, SJC, and depressive symptoms between visits were scores of the corresponding variables at the previous visit. However, there was evidence of a small but consequential bidirectional relationship between depressive symptoms and pain. Previous SF-36 mental component summary (MCS) scores and change in MCS scores were associated with change in pain between visits.

Conversely, previous pain scores and change in pain scores were associated with change in depressive symptoms between visits.

The authors suggested that a clinical approach that assesses and manages depressive symptoms as well as pain in patients with PsA could enhance patient outcomes.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.